Insurance Coverage of Biosimilars: Prior Authorization and Tier Placement Strategies
Biosimilars can cut drug costs by up to 33%, but most insurance plans treat them like brand-name biologics-same tier, same prior authorization, same high out-of-pocket costs. Here’s how coverage works and what you can do about it.
read more